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SUMMARY
The issue of life-ending has been a source of considerations since the dawn of civiliza-
tion, and calls for great circumspection when one attempts to fit it socially throughout 
the history of human thinking. The development and improvement of Medicine might 
modify, in most cases, the natural history of disease. We have managed to prolong life 
and the process of dying. This has created a new medical prototype that needs to care 
for terminally-ill patients, a situation often accompanied by severe suffering. Society at-
tributes to the physician the role of being responsible for conquering and overcoming 
death. In the oncology context, these questions are well addressed, as in many situations 
there is no possibility to offer a curative treatment to the patients. The objective of the 
present study was to discuss the relations that guide the proposed theme, based on a 
medical literature review. Therefore, a perspective is sought as an argumentative alterna-
tive that brings evidence to the proposed debate.
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CONTEXTUALIZATION OF THE PROBLEM
The word “palliative” refers to the Latin word pallium 
(blanket). Patients who could not be treated had their 
wounds covered1. The idea of  organizing palliative care 
was conceptualized in 1960 by Cicely Mary Strode 
Saunders (Saint Christopher Hospice in London). She 
described the philosophy of caring for individuals diag-
nosed with terminal incurable diseases. For her, the pain 
that terminally-ill individuals experienced consisted of 
four elements: physical pain, psychological pain (emo-
tional), social pain and spiritual pain2. 
Thus, caregivers should work in all these situations to 
relieve suffering and to comfort patients and their fami-
lies, in order to try to obtain gain in quality of life. More-
over, it was clearly opposed to all pointless and technolo-
gy-laden practices for healthcare, or the unnecessary use 
of expensive and invasive treatments for patients with no 
prospective cure. In 1990, the World Health Organiza-
tion (WHO) defined palliative care as the “active and 
total care of patients whose disease no longer responds 
to curative treatments. Control of pain and symptom 
management, care of psychological, social and spiritual 
problems are the most important ones. The goal of pallia-
tive care is to achieve the best possible quality of life for 
patients and their families”.   
When speaking of death, everyone imagines it as pain-
free, fast and preferably during sleep. To think of death 
and to face it is something di cult, as it exposes distant 
memories of loss, grief and the fear of a mysterious and 
uncertain future. Thus, there is an attempt to suppress it 
from everyday life, as the death claim is evidence of our 
own limitations, of our finitude. From the philosophical 
point of view, several authors wrote about its meaning: 
Hegel3 denied the primacy of finitude as the primary ques-
tion of human existence, articulating a discourse aiming 
at overcoming death, whereas for Heidegger4, finitude is 
considered an inalienable human dimension. 
The scientific and technological advances have al-
lowed the process of medicalization of dying and of death 
itself. The traditional death that occurred while the pa-
tient was assisted by family members and loved ones in 
bed at home was replaced by the hospital environment, 
with the company of numerous equipment and busy pro-
fessionals. Thus, death has become a solitaire affair and 
thus, terrifying; the rites of death are simplistic, the sup-
pression of pain and medicalization of grief is prescribed 
instead of the once usual manifestations5. This context 
conspicuously promotes the figure of the physician. The 
development and improvement in Medicine might mod-
ify, in most cases, the natural history of disease. We have 
managed to prolong life and the process of dying. This 
has created a new medical prototype that needs to care 
for terminally-ill patients, a situation often accompanied 
by severe suffering6. 
Moreover, society attributes to physicians the role of 
being responsible for conquering and overcoming death; 
they are the tanatholytic beings7 (from the Greek: thana-
tos=death and lytic=destruction), those who decide the 
moment of death and the dying context. The physician 
thus becomes omnipotent, and his priority is to save at 
any cost, in order to meet the projected expectations of a 
life preserver. Thus, doctors bear the high social expecta-
tion that is expressed in several ways. Within this context, 
and in the presence of incurable diseases, the physician is 
faced with his insignificance in the presence of irrevers-
ible pictures. Consciously or unconsciously, the physician 
faces his own finitude, which is frustrating. Consequently, 
afraid of these feelings, he begins to indoctrinate himself 
in the distancing and dehumanizing coldness.  
Neutrality, alienation and indifference to the patient 
are said to be prerequisites for good performance, as 
they ward off the disquiet of the professional in the face 
of the death of the other and his own death. Therefore, 
physicians tend not to confront the reality of death, a fact 
that becomes a source of suffering, being a taboo subject, 
which they seek to avoid. 
Often the onset of this problem occurs in the aca-
demic environment. Medical students tend to seek the 
profession precisely because it is a di cult and challeng-
ing area. Thus, they aim at the status of a powerful being 
that will cure all diseases, prevent people from dying and 
save all lives. The knowledge of this psychological phe-
nomenon, usually called the illusion of omnipotence8, 
is extremely important to try to understand its several 
manifestations and professional behaviors. It is also 
known that the environment of medical education tends 
to emphasize the challenge, the study, the responsibility 
and tends to greatly stimulate competition. Considering 
that individuals with a highly competitive spirit tend to 
be valued in our society, a feedback circle is formed, in 
which the professional is progressively burdened and at 
the same time, admired and acknowledged for it. 
This emotional vulnerability can affect the physician 
in the development of his activities regarding the sick, in 
addition to affecting himself, which can lead to an over-
load, called “burnout syndrome”, characterized by physi-
cal and emotional exhaustion, depersonalization and de-
creased capacity of personal achievement. It refers to a 
type of chronic emotional stress of individuals who care 
very intensely for another9. 
In the oncological context, in the last decades, due 
to the technical-scientific developments and medical 
prevention, diagnosis and treatment of tumors, we have 
managed to increase the overall survival and quality of 
life of patients. However, the word “cancer” still carries a 
huge negativistic stigma of imminent death, which gen-
erates quite a lot of anguish and suffering for patients, 
families and caregivers. 
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THE PHYSICIAN IN THE FACE OF A PATIENT’S CANCER 
DIAGNOSIS AND PROGNOSIS
Doctors’ attitudes in the face of a cancer diagnosis of their 
patients and their family members are sometimes wrong, 
starting with the distancing and poor provision of infor-
mation to them. In interviews carried out with a group of 
healthcare professionals10, although 97.4% of physicians 
generally inform their patients of the diagnosis in cases 
of terminal illness, half took advantage of family support 
to do so. Regarding the information about a fatal prog-
nosis, those who reported only to the family were 63.1%, 
while 31.6% preferred to pass the information directly 
to the patient. This can be interpreted, according to the 
study, as the misperception made by the professional be-
tween beneficence, paternalism and countertransference. 
This detachment can cause sequelae that might im-
pair the patient’s wishes. A multicenter Japanese study11 
assessed 450 terminally-ill patients with their respective 
families and physicians regarding the desire for cardio-
pulmonary resuscitation or dialysis. The same analysis 
tools were used for the patients, their families and their 
physicians. Only 68% and 60% respectively of the fami-
lies and physicians knew how to predict the patients’ 
wishes for cardiopulmonary resuscitation. Regarding 
dialysis, 67% and 68% did. The known relationship be-
tween the physician and the families of patients who are 
at the end of life presents a challenge and an opportunity 
for a poorly-prepared physician12. The family plays an ex-
tremely important part for the patient at the end of his 
life, both practically and emotionally. Physicians should 
improve their communication with the families, help in 
care-planning and decision-making, help bring together 
patients and families at home, maintain empathy for the 
emotions and relationships of the family with the patient 
and bereavement assistance. 
Even when analyzing the other side, i.e., the news of a 
good chance of cure with treatment is also directly con-
nected to a good doctor-patient relationship. 
A North-American study13 assessed 101 patients and 
their oncologists on the relaying of information on prog-
nosis. First, the strength of the doctor-patient interaction 
was measured with questionnaires and subsequently, the 
expectations of patients were analyzed. After the relaying 
of prognostic information, patient adherence to the treat-
ment offered by the oncologist was also analyzed. The 
strength of the doctor-patient interaction was statistically 
associated with the patient’s likelihood to follow the ad-
vice of the oncologist. The patient-family-physician bond 
also becomes important in the initial decision of the 
treatment, as shown in this study14 with 57 patients with 
breast cancer. Ninety-three percent of the patients felt re-
sponsible for their own decision about treatment, but up 
to 89% of cases the agreement with their husbands was a 
key part in the decision.
The diagnosis of cancer is not communicated to pa-
tients in the majority of the times, especially if done 
by physicians that are not specialists in cancer. A pro-
spective study15 evaluated 396 patients and their family 
members referred by 76 physicians to a surgical oncolo-
gy outpatient clinic. The rate of diagnostic omission was 
28.5%. The non-specialized physicians did not inform 
87.9% of their patients, while the specialists omitted the 
diagnosis in 6.4% of cases. Family members were not in-
formed only in 27.4% of cases. In 14.2% of cases, fam-
ily members asked, during the pre-consultation at the 
outpatient clinic, for the patient to not be informed of 
the disease. 
From the ethical point of view, the information must 
belong to and be given to the patient, but not necessarily 
to the family. However, what is the patient’s expectation 
when receiving information that could change his or her 
life? How will the physician know if the patient is capa-
ble of absorbing this shocking information? Very often, 
the physician has known the patient for too short a time 
to know if he or she is able to manage such devastating 
information about him or herself. 
Often family members offer their help, because the 
patient and his family are part of a range of dynamic in-
teraction, balanced prior to the diagnosis of cancer, but 
now disrupted. Kallergi16 proposes the following steps to 
facilitate this process: (1) to know about the personality 
and denial of the patient, (2) to measure the intensity of 
the patient’s relationship with his/her family, (3) to pro-
pose a meeting with the patient and his/her family, and 
(4) to decide how to inform the patient. 
The information about cancer has cultural and geo-
graphical inuences. The question of how and how much 
to tell patients about the cancer diagnosis should be ap-
proached differently, depending on the cultural charac-
teristics of each people17. Most physicians more often 
tell the truth today than in the past, both in developed 
and developing countries, but most of them prefer to re-
veal the truth to the next-of-kin. Nurses in Anglo-Saxon 
countries are considered as the most suitable profession-
als to give healthcare to patients and share their thoughts 
and feelings18.  
However, in most other cultures, the final decision 
on information disclosure lies with the physician. Re-
gardless of cultural origin, the diagnosis of cancer affects 
both the family structure and dynamics19. In most cas-
es, the families, in an effort to protect the patient from 
despair and a feeling of hopelessness, exclude him/her 
from the process of exchanging information. The health-
care team-patient relationship is a triangle formed by the 
health professional, the patient and the family. Each part 
supports the other two and is affected by the cultural 
context of each of the others, as well as changes that oc-
cur within the triangle20. 
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BUT THEN, WHERE IS THE LIMIT?
When we seek at the sources of information about treat-
ment indications, the answer is always associated with 
the patient’s performance status index, age, comorbidi-
ties, clinical conditions to withstand the treatment, ex-
pected benefits and wishes and desires of the patient and 
family. There is a range of options for cancer treatments 
that can help the sick at the end of their lives. A practi-
cal and hypothetical example: male patient aged 68 years, 
diagnosed with glioblastoma multiforme, with lesions oc-
cupying 35% of the right cerebral hemisphere and signifi-
cant edema/mass effect. Surgery ruled out due to patient’s 
comorbidities. Karnofsky Performance Status Scale21 of 70 
(scale ranging from 0 to 100, where 0 is death and 100 is a 
healthy person). Proposed treatment: brain radiotherapy, 
to be carried out in six weeks, associated with chemo-
therapy with temozolomide. Level I medical evidence that 
supports such conduct. Expected benefits of treatment: 
prolong the median survival of patients like this from 9 to 
16 months.  
The decision involves all of the above mentioned. But is 
there something else to offer radiation therapy in less time, 
or not to offer chemotherapy, or not to treat oncologically, 
providing clinical support only? Apart from factors related 
to our reality: if the patient knocks on the door of a public 
hospital, he will have “X” treatment after the waiting list. 
If he is contemplated with the possibility of being treated 
by the health insurance system, he will receive treatment 
“X + 1” or even “X - 1.” If the patient is being treated at 
his own expenses, he will also receive treatment “Y”, which 
is available only in hospital “Z”. If perchance the patient 
boards a plane heading to the centers of excellence world-
wide, will receive the treatment indication “W”, as it is an 
experimental protocol and such centers of excellence can-
not offer treatment “W” to any patients at risk of hurting 
legislative and ethical principles of their country.  
Then, when we search for sources of medical evi-
dence, there are no guidelines, consensuses, even articles 
with evidence level I or II involving the keywords cancer 
and withdraw treatment, surveyed in the main electronic 
databases (Pubmed, Embase, Lilacs and Cochrane data-
bases). It is not possible to base oneself on ideas built with 
population samples chosen for a clinical trial that can be 
extrapolated to our daily lives. It is, however, possible to 
base oneself for the indication and contraindication. Thus, 
the dilemma relayed by the title of this article is faced: 
when to stop offering treatments that are so exciting for 
medical practice? 
The physician hungry for cures cannot know his own 
limit, and due to his technical perfection, often manages 
to convince patients and family members to accept all the 
treatments proposed by him. Thus, this process of prolong-
ing the unprolongable often makes families end up expe-
riencing anticipatory grief. This entity may take the form 
of sadness, anxiety, attempts to settle the problems of an 
open relationship, and efforts to restore or strengthen fam-
ily ties. Anticipation is a chance to prepare psychologically 
for death, but that is being delayed by futile treatments. 
Is this the story that everyone expects? Just as physi-
cians do not have answers, families do not know how or 
where to seek support. It is known that cancer is always 
the biggest culprit, due to its stigma, its inherent severity. 
HOLISTIC PALLIATIVE CARE APPROACH TO THE ONCOLOGIC 
PATIENT IN THE PRESENT DAY 
Palliative care started in the face of life-threatening illness 
require interdisciplinary collaboration, which focuses on 
goals of care and relief of suffering of the patient and fam-
ily, extending to the mourning period and after the death 
of the patient. Although the assessment of palliative care 
includes all the standard elements of a detailed medical 
history and relevant aspects of the physical examination, 
it also extends to areas beyond the traditional approach. 
As an example, the sense of the person and his/her body 
image, the sense of the past, the sense of the future, what 
the disease means for the patient, his/her desires, relation-
ships, values  or spiritual beliefs contribute to the experi-
ence of illness. 
The importance of these principles was illustrated in a 
study that followed 358 patients undergoing bone marrow 
transplantation, evaluated medically, psychologically and 
socially22. Psychological and social variables were signifi-
cant predictors of pain levels after transplantation. A simi-
lar study of a cohort of 1,582 patients found that higher 
levels of comorbidity, less independence in activities of 
daily life before the illness, and worse perceived quality 
of life were associated with higher symptom load23. Sub-
sequent investigations have confirmed the impact of emo-
tional stress on the perception of cancer pain24. 
Not only the burden of disease increases with several 
combinations of symptoms, but certain conditions also 
contribute to the desire of patients to face a premature 
death. Depression and hopelessness were the strongest 
predictors of desire for an early death in terminally-ill 
cancer patients25. The substantial impact of psychological 
stress was also confirmed in cancer patients admitted for 
palliative care26. The key factors in the desire for an early 
death were depression, physical functional status, pain, 
hopelessness and social support.  
In other words, these data suggest that the under-
standing of a severely ill patient with pain and suffering, 
be treated as a complex phenomenon27 that requires a 
structured and systematic approach. Both subjective and 
objective elements are essential to an assessment of pal-
liative care. One researcher proposed that the subjective 
component of the assessment should not be limited to the 
exhaustive cataloging of disease symptoms28. Rather, it 
needs to be based on an attitude of openness towards the 
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other person, being present to another’s suffering. Hence, 
the diagnostic evaluation becomes part of a therapeutic in-
tervention. Several evaluation methods based on domains, 
representing the variability of weight and preferences at 
the end of life, have been proposed. The PEACE tool cov-
ers six domains29: physical, emotional and cognitive symp-
toms, autonomy, communication and contribution to oth-
ers, economic impact and existential issues. 
In summary, we found that this kind of systematic and 
comprehensive evaluation has several advantages over less 
structured formats30. Thus, we promote the correspon-
dence between the true self-assessment of the patient, of the 
domains of suffering with the objective evaluation 
of the data collected and recorded by the physician, which 
creates a favorable environment to bring together caregiv-
ers and patients. It is important to mention that the use of 
multidimensional tools such as the aforementioned one 
would encourage interdisciplinary work, which is the hall-
mark of palliative care. Patient evaluation along several do-
mains not only helps to elucidate the nature of pain (somat-
ic, emotional, spiritual), but also invites and involves the 
experience of other members of the palliative care team. 
Specifically in the case of cancer, most patients will de-
velop, weeks or months before death, potentially devastating 
symptoms, both physical and psychosocial ones31. Patients 
admitted to tertiary palliative care units tend to present 
with more frequent and severe symptoms. Pain, although 
not the most common symptom, is the most distressing one 
and feared by patients and families. The following features 
can complicate the management of terminally-ill cancer 
patients32: older age (>65years), malnutrition, low serum 
albumin, autonomic deficits, impaired renal function, cog-
nition problems, low seizure threshold, prolonged use of 
opioids and treatments with multiple drugs. This translates 
into the increased toxicity of most interventions, either 
pharmacological or nonpharmacological ones. 
Terminally-ill patients are symptomatic, debilitated, 
and very often are emotionally fragile. Thus, open and 
regular communication by means of family conferences 
is essential for adequate palliation. Some prospective co-
hort studies in intensive care units have shown that these 
conferences are associated with improvement in family 
satisfaction, decrease in length of hospital stay, and greater 
access to palliative care, with no increase in mortality33.
Specifically in cases of cancer patients, there are few 
data on the impact of family meetings on patients with ad-
vanced cancer and their caregivers. A comparative study34 
shows that caregivers have different information about the 
prognostic needs and other issues of end of life, often dif-
fering from the patient’s needs. Furthermore, information 
preferences may change over time, as exemplified by this 
study35, showing that terminal cancer patients usually ask 
few questions about their diagnosis and, in general, are less 
involved in making decisions about disease progression. 
Professionals who may come into contact with cancer 
patients should try to make an assessment of the impact 
of disease and treatment on the patient’s functional status. 
Many physicians abdicate from this holistic assessment for 
the obstinacy and haste for the diagnosis and start of the 
therapy considered to be the most effective. Taking a little 
time to perform a systematic review of the physical, emo-
tional and social consequences of cancer can be an impor-
tant first step in understanding the patient’s response dur-
ing the disease process.
While most cancer survivors recover from the treat-
ments and find a positive meaning in the experience of 
cancer, others will have problems and functional com-
plaints as a result of treatment. The discussion of their 
concerns, of appropriate rehabilitation interventions and 
support is critical to health maintenance. Patients with ad-
vanced cancer have several associated pathologies that are 
amenable to clinical intervention, even if the underlying 
disease cannot be cured36. To promote the effective man-
agement of symptoms is essential to maintain the patient’s 
functional status, particularly and preferably in the multi-
disciplinary sphere.   
FINAL CONSIDERATIONS
Human beings are aware of their finitude, but they are 
used to value natural causes of death (old age, accidents, 
diseases), reducing their need for a causal fact, thus de-
nying its inevitability. To think of death and to face it in 
its essence can be di cult, as it exposes distant memories 
of loss, grief and the fear of a mysterious and uncertain 
future. Health professionals tend not to confront the in-
exorable reality of death, as that would bring suffering 
to themselves, constituting a taboo they seek to avoid. In 
this context, many physicians, in connivance with family 
members or not, are reluctant to inform patients about 
their actual situation, either by explicitly omitting the di-
agnosis, or implicitly by using incomprehensible technical 
terms. Thus, the physician-patient lack of communication 
is corroborated: the patient is kept from something that is 
rightfully his, which generates a fragile relationship, based 
on the patient’s lack of trust regarding his or her caregiver, 
as well as ethical violations. 
Regarding the current universe of cancer treatment, 
this di cult path receives clear directions, as the physician 
always aims to heal and seeks, at all costs, to provide all 
the available resources. But there is no way up. There are 
not enough references; only medical education biases and 
the stigma of the disease, which is a major cause of death 
throughout the world today. 
The clarification and proposed discussion of issues 
such as this invisible boundary of “to treat” or “not to 
treat” is a potential source of education. Clinical, psycho-
logical and social studies should be strongly encouraged.  
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